CSL BEHRING LLC for CSL BEHRING LLC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3/S. 2543--Lower Drug Costs Now Act; Prescription Drug Pricing Reduction Act; Administration Advance Notice of Proposed Rulemaking on International Pricing Index; International Pricing Index, Inflation Cap Medicare Rebates H.R. 2905--Medicare IVIG Enhancement Act--Legislation that would create a home infusion benefit under Medicare Part B for intravenous immunoglobulin (IVIG) when used in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP). Allowance of reimbursement for product and administration of durable medical equipment administered drugs (subcutaneous immune globulin specifically) that are listed on self administered drug lists by Medicare contractors. H.R. 2296--METRIC Act--Drug Price transparency reporting requirements
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | — |
| JULIA GRANT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.